Atrial Fibrillation (A-Fib) – Diagnosis, Treatment, and Complications
Having Atrial Fibrillation (A-Fib) can be a devastating condition, but there are treatment options for this condition. In this article, we’ll discuss the diagnosis, treatment options, and complications of this condition.
Symptoms of A-Fib include dizziness, fatigue, and difficulty breathing. Often, these symptoms occur without warning. If they occur repeatedly, you may need to be treated for atrial fibrillation.
A diagnosis of atrial fibrillation is made using an electrocardiogram (ECG). An ECG is an electrical recording of your heartbeat. It can be done in the doctor’s office or at home.
To diagnose atrial fibrillation, doctors will ask you about your medical history and symptoms. They will also check your heart’s rate and rhythm.
The doctor may also order blood tests. These tests can help determine whether you have other health conditions that may be contributing to A-Fib. They can also help the doctor select the best medicine.
A doctor may also prescribe medications that can control your heart rate. These medications can help prevent blood clots from forming in your arteries, and they can also lower the risk of stroke.
Your doctor may also recommend that you undergo catheter ablation, a procedure that involves destroying a small area of heart tissue. This procedure will reset your heart’s normal rhythm.
Your doctor may also recommend that you get a Holter monitor. This device is worn for up to a week. It includes sensors that connect to a device that you wear on your shoulder strap.
Atrial fibrillation can be treated with medication and surgery. It can also be controlled through lifestyle changes. These include reducing alcohol consumption and stress. You may also need to try several treatments before finding the right one for you.
In some cases, atrial fibrillation will go away on its own. However, the disorder is very serious and can increase your risk of developing heart failure and stroke. It is important to have your diagnosis treated quickly to prevent serious medical complications.
Surgical and non-surgical treatments are available for atrial fibrillation. These treatments will vary depending on the severity of the condition and underlying health conditions.
The goal of atrial fibrillation treatment is to normalize the heart rate and decrease the risk of stroke. Your physician will discuss the treatment options with you. Some of the treatments involve medication. Anti-arrhythmic medications are often used to control the heart rate and reduce the risk of stroke. However, they are only effective 30 to 60 percent of the time.
Surgical treatments may include open-heart surgery or maze surgery. Surgical ablation involves cutting small holes in the upper chambers of the heart to block abnormal electrical circuits. Other surgeries include surgery to repair dysfunctional heart valves.
The first step of treatment is to find out what caused your atrial fibrillation. This is done by performing an echocardiogram or stress test. An echocardiogram is a test that uses sound waves to create images of the heart. A stress test involves running tests on the heart while you exercise.
Atrial fibrillation is a condition that affects millions of people in the United States. It is caused by abnormal electrical firing in areas of the heart that connect to the left atrium. Some people may not experience any symptoms of atrial fibrillation, while others may have numerous episodes of afib. Afib can result in strokes, heart failure, and fatigue.
Anticoagulant medications are used to prevent blood clots in the veins. Blood clots can block an artery in the brain, causing a stroke. Anticoagulants are often given for three to four weeks before cardioversion. If cardioversion is successful, anticoagulants may be discontinued.
Atrial fibrillation treatments include medicines to control the heart rate, surgery to repair heart valves, and procedures to restore a normal heart rhythm. Treatment options may be provided by your cardiologist or general practitioner.
Having an irregular heartbeat (arrhythmia) is not life-threatening, but it can be dangerous to your health. This is because an irregular heartbeat can lead to blood clots and a stroke. These blood clots can block blood flow to other parts of the body, such as the brain or the lungs. It is important to get a diagnosis of atrial fibrillation and have it treated before complications develop.
Atrial fibrillation (AF) is a common condition that occurs when the upper chambers of the heart (atria) do not contract properly. It can also cause other problems in the heart, including heart failure. Often, it is asymptomatic but can cause pain or shortness of breath. The symptoms of atrial fibrillation include palpitations, shortness of breath, fatigue, and dizziness.
There are several types of treatment for atrial fibrillation, including medications to control the heart rate and surgery to restore a normal rhythm. A cardiologist can help you decide which type is best for you.
Catheter ablation, which uses radiofrequency energy to kill tissue, can also be used to treat atrial fibrillation. It is a minimally invasive procedure. The procedure can be performed in several different centers around the world.
Cardioversion is a heart-rhythm-reset procedure, which usually takes place in a hospital setting. The patient is given an oral anticoagulant for three to four weeks before cardioversion. Anticoagulants are given again for four weeks after cardioversion.
Atrial fibrillation has a higher risk of stroke and blood clots. A stroke can be caused by a blood clot in the lungs, the heart, or the brain. A blood clot can also block the blood flow to the heart, which can cause heart failure.
A stroke can also be caused by a blood clot that forms in the heart (atrial thrombosis) or a clot in the lungs (pulmonary embolism). A clot in the lungs can block the blood supply to the brain, which can cause brain damage.
Approximately 90% of all clots in people with atrial fibrillation originating from the left atrial appendage (LAA). Using a Watchman device to close the left atrial appendage will reduce the risk of ischemic strokes and blood clots. It is a one-time procedure.
Typically, the WATCHMAN procedure lasts about an hour and is performed under general anesthesia. During the procedure, a catheter is placed into the left atrial appendage and a Watchman device is inserted. The Watchman device is covered with a permeable polyester fabric and then expanded. It is then affixed to the LAA ostium by anchors. The Watchman device is a self-expanding nickel-titanium structure.
The Watchman device is intended for patients with non-valvular atrial fibrillation who are at moderate to high risk for thromboembolism and stroke. It is an innovative treatment option for patients who are unsuitable for warfarin. It is also used as an alternative treatment for patients who are ineligible for (N)OAC therapy. It is available in five sizes.
The WATCHMAN device has been studied in two randomized clinical trials. These studies compared the Watchman device with long-term warfarin therapy in patients with atrial fibrillation. In both studies, the Watchman device had a favorable complication rate. Among the patients who received the Watchman device, the overall rate of procedure-related mortality was 0.08%, and the rate of procedure-related stroke was 0.08%.
In the clinical trials, the rate of all-cause stroke and systemic embolism was 2.3% and 2.3%, respectively. Compared to the warfarin group, the Watchman group had a lower risk of stroke.
The Watchman device has been registered in 75 countries and has been used in more than 10,000 procedures. It is the only percutaneously delivered LAA occlusion device.
Various studies have shown that catheter ablation is effective in improving outcomes in patients with atrial fibrillation and heart failure. It has also been shown to reduce the risk of death in the elderly. However, the long-term effects of catheter ablation remain uncertain. In order to develop a more accurate modeling approach, it is necessary to examine the longer-term outcomes of ablation. In addition, the benefits of catheter ablation must be balanced against the costs of the procedure and the healthcare utilization benefits that may be associated with it.
In the Symplicity AF clinical trial, patients with atrial fibrillation were randomly assigned to receive either medical therapy or catheter ablation. Medical therapy was used in the majority of patients. In addition, the ablation group had significantly lower mortality compared with the control group.
Atrial fibrillation is associated with significant morbidity and mortality. Although catheter ablation may reduce the burden of atrial fibrillation, it may increase the risk of recurrence. Thus, it is important to determine the long-term effects of catheter ablation on patient health and mortality.
In the CABANA study, patients were randomly assigned in a 1:1 ratio to receive either ablation or medical therapy. Patients were followed for a median of 54 months. In addition to the primary endpoint, secondary endpoints included unplanned overnight hospitalization for heart failure, death from any cause, and death from cardiovascular disease.
For patients in the ablation group, the most important result was the reduction in the risk of cardiovascular death. The ablation group also had a lower rate of hospital admission for heart failure. A significant decrease in the hazard ratio for cardiovascular death occurred after the last ablation attempt. A Kaplan-Meier curve was also observed.
Health A to Z. (n.d.). HSE.ie. https://www2.hse.ie/az/
U.S. National Library of Medicine. (n.d.). https://www.ncbi.nlm.nih.gov/
Directory Health Topics. (n.d.). https://www.healthline.com/directory/topics
Health A-Z. (2022, April 26). Verywell Health. https://www.verywellhealth.com/health-a-z-4014770
Harvard Health. (2015, November 17). Health A to Z. https://www.health.harvard.edu/health-a-to-z
Health Conditions A-Z Sitemap. (n.d.). EverydayHealth.com. https://www.everydayhealth.com/conditions/